Taxpayers foot the bill for medical research, but companies profit. We're paying for drugs twice and this needs to change now
For equitable drug access, we need a new R&D model.
Source: zmescience.com
Stay updated with breaking news from Dole Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For equitable drug access, we need a new R&D model.
Opinion | Taxpayers foot the bill for medical research, but companies profit. For equitable drug access, we need a new R&D model.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Commentary After forty-eight years of leading the U.S. government’s responses to infectious diseases, Dr. Anthony Fauci recently announced ...
In recent days, increased attention has been given to government funding on the national and state level, for example, through investment in our country's infrastructure.